TDP-43 regulates β-adducin (Add2) transcript stability

RNA Biology

Volumn 11, Issue 10, 2014, Pages 1280-1290

  Costessi, Luisa ^a   Porro, Fabiola ^a   Iaconcig, Alessandra ^a   Muro, Andrés F ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

Author keywords

3 end processing; 3 UTR; Add2; DSE; mRNA stability; TDP 43

Indexed keywords

BETA ADDUCIN; MEMBRANE PROTEIN; MESSENGER RNA; MESSENGER RNA PRECURSOR; SMALL INTERFERING RNA; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG; ADD2 PROTEIN, HUMAN; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; PROTEIN TDP-43; RNA BINDING PROTEIN; RNA PRECURSOR;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOTOR COORDINATION; NERVE CELL PLASTICITY; NORTHERN BLOTTING; POLYADENYLATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN STABILITY; RNA CLEAVAGE; SYNAPSE; ANIMAL; GEL MOBILITY SHIFT ASSAY; GENETICS; METABOLISM; MOUSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA STABILITY; WESTERN BLOTTING;

MUS;

ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CYTOSKELETAL PROTEINS; DNA-BINDING PROTEINS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENE EXPRESSION REGULATION; HEK293 CELLS; HELA CELLS; HUMANS; MICE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; POLYADENYLATION; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA PRECURSORS; RNA STABILITY; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84921984614     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.1080/15476286.2014.996081     Document Type: Article

References (45)

1. Keene JD. RNA regulons: coordination of post-transcriptional events. Nat Rev Genet 2007; 8:533-43; PMID:17572691; http://dx.doi.org/10.1038/nrg2111
2. Wu X, Brewer G. The regulation of mRNA stability in mammalian cells: 2.0. Gene 2012; 500:10-21; PMID:22452843; http://dx.doi.org/10.1016/j.gene.2012.03.021
3. Lenzken SC, Achsel T, Carri MT, Barabino SM. Neuronal RNA-binding proteins in health and disease. Wiley Interdiscip Rev RNA 2014; PMID:24687864; 10.1002/wrna.1231
4. Buratti E, Baralle FE. The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol 2010; 7:420-9; PMID:20639693; http://dx.doi.org/10.4161/rna.7.4.12205
5. Hanson KA, Kim SH, Tibbetts RS. RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond. Wiley Interdiscip Rev RNA 2012; 3:265-85; PMID:22028183; http://dx.doi.org/10.1002/wrna.111
6. Fiesel FC, Kahle PJ. TDP-43 and FUS/TLS: cellular functions and implications for neurodegeneration. FEBS J 2011; 278:3550-68; PMID: 21777389; http://dx.doi.org/10.1111/j.1742-4658.2011.08258.x
7. Buratti E, Baralle FE. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 2001; 276:36337-43; PMID:11470789; http://dx.doi.org/10.1074/jbc.M104236200
8. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 2011; 14:459-68; PMID:21358643; http://dx.doi.org/10.1038/nn.2779
9. Sephton CF, Cenik C, Kucukural A, Dammer EB, Cenik B, Han Y, Dewey CM, Roth FP, Herz J, Peng J, et al. Identification of neuronal RNA targets of TDP-43-containing ribonucleoprotein complexes. J Biol Chem 2011; 286:1204-15; PMID:21051541; http://dx.doi.org/10.1074/jbc.M110.190884
10. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, Konig J, Hortobagyi T, Nishimura AL, Zupunski V, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 2011; 14:452-8; PMID:21358640; http://dx.doi.org/10.1038/nn.2778
11. Xiao S, Sanelli T, Dib S, Sheps D, Findlater J, Bilbao J, Keith J, Zinman L, Rogaeva E, Robertson J. RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS. Mol Cell Neurosci 2011; 47:167-80; PMID:21421050; http://dx.doi.org/10.1016/j.mcn.2011.02.013
12. Mackenzie IR, Rademakers R, Neumann M. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia. Lancet Neurology 2010; 9:995-1007; PMID:20864052; http://dx.doi.org/10.1016/S1474-4422(10)70195-2
13. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314:130-3; PMID:17023659; http://dx.doi.org/10.1126/science.1134108
14. Lee EB, Lee VM, Trojanowski JQ. Gains or losses: molecular mechanisms of TDP43-mediated neurodegeneration. Nat Rev Neurosci 2012; 13:38-50; PMID:22127299; http://dx.doi.org/10.1038/nrn3121
15. Costessi L, Porro F, Iaconcig A, Nedeljkovic M, Muro AF. Characterization of the distal polyadenylation site of the ss-adducin (Add2) pre-mRNA. PloS one 2013; 8:e58879; PMID:23554949; http://dx.doi.org/10.1371/journal.pone.0058879
16. Avendano-Vazquez SE, Dhir A, Bembich S, Buratti E, Proudfoot N, Baralle FE. Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev 2012; 26:1679-84; PMID:22855830; http://dx.doi.org/10.1101/gad.194829.112
17. Gilligan DM, Lozovatsky L, Gwynn B, Brugnara C, Mohandas N, Peters LL. Targeted disruption of the βadducin gene (Add2) causes red blood cell spherocytosis in mice. Proc Natl Acad Sci U S A 1999; 96:10717-22; PMID:10485892; http://dx.doi.org/10.1073/pnas.96.19.10717
18. Muro AF, Marro ML, Gajovic S, Porro F, Luzzatto L, Baralle FE. Mild spherocytic hereditary elliptocytosis and altered levels of α- and gamma-adducins in β-adducin-deficient mice. Blood 2000; 95:3978-85; PMID:10845937
19. Tripodi G, Piscone A, Borsani G, Tisminetzky S, Salardi S, Sidoli A, James P, Pongor S, Bianchi G, Baralle FE. Molecular cloning of an adducin-like protein: evidence of a polymorphism in the normotensive and hypertensive rats of the Milan strain. Biochem Biophys Res Commun 1991; 177:939-47; PMID:2059221; http://dx.doi.org/10.1016/0006-291X(91)90629-L
20. Matsuoka Y, Li X, Bennett V. Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons. J Cell Biol 1998; 142:485-97; PMID:9679146; http://dx.doi.org/10.1083/jcb.142.2.485
21. Seidel B, Zuschratter W, Wex H, Garner CC, Gundelfinger ED. Spatial and sub-cellular localization of the membrane cytoskeleton-associated protein α-adducin in the rat brain. Brain Res 1995; 700:13-24; PMID:8624703; http://dx.doi.org/10.1016/0006-8993(95)00962-P
22. Bednarek E, Caroni P. β-Adducin is required for stable assembly of new synapses and improved memory upon environmental enrichment. Neuron 2011; 69:1132-46; PMID:21435558; http://dx.doi.org/10.1016/j.neuron.2011.02.034
23. Pielage J, Bulat V, Zuchero JB, Fetter RD, Davis GW. Hts/Adducin controls synaptic elaboration and elimination. Neuron 2011; 69:1114-31; PMID:21435557; http://dx.doi.org/10.1016/j.neuron.2011.02.007
24. Porro F, Rosato-Siri M, Leone E, Costessi L, Iaconcig A, Tongiorgi E, Muro AF. β-adducin (Add2) KO mice show synaptic plasticity, motor coordination and behavioral deficits accompanied by changes in the expression and phosphorylation levels of the α- and gamma-adducin subunits. Genes, Brain Behav 2010; 9:84-96; PMID:19900187; http://dx.doi.org/10.1111/j.1601-183X.2009.00537.x
25. Rabenstein RL, Addy NA, Caldarone BJ, Asaka Y, Gruenbaum LM, Peters LL, Gilligan DM, Fitzsimonds RM, Picciotto MR. Impaired synaptic plasticity and learning in mice lacking β-adducin, an actin-regulating protein. J Neurosci 2005; 25:2138-45; PMID:15728854; http://dx.doi.org/10.1523/JNEUROSCI.3530-04.2005
26. Costessi L, DevescoviG, Baralle FE, Muro AF. Brain-specific promoter and polyadenylation sites of the β-adducin pre-mRNA generate an unusually long 3′-UTR. Nucleic Acids Res 2006; 34:243-53; PMID:16414955; http://dx.doi.org/10.1093/nar/gkj425
27. Shi Y, Di Giammartino DC, Taylor D, Sarkeshik A, Rice WJ, Yates JR, 3rd, Frank J, Manley JL. Molecular architecture of the human pre-mRNA 3' processing complex. Molecular cell 2009; 33:365-76; PMID:19217410; http://dx.doi.org/10.1016/j.molcel.2008.12.028
28. Nedeljkovic M, Costessi L, Iaconcig A, Porro F, Muro AF. Long-distance regulation of Add2 pre-mRNA3′ end processing. RNA Biol 2013; 10:516-27; PMID:23411391; http://dx.doi.org/10.4161/rna.23855
29. Ayala YM, De Conti L, Avendano-Vazquez SE, Dhir A, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E, et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 2011; 30:277-88; PMID:21131904; http://dx.doi.org/10.1038/emboj.2010.310
30. Colombrita C, Onesto E, Megiorni F, Pizzuti A, Baralle FE, Buratti E, Silani V, Ratti A. TDP-43 and FUS RNA-binding proteins bind distinct sets of cytoplasmic messenger RNAs and differently regulate their posttranscriptional fate in motoneuron-like cells. J Biol Chem 2012; 287:15635-47; PMID:22427648; http://dx.doi.org/10.1074/jbc.M111.333450
31. Strong MJ, Volkening K, Hammond R, Yang W, Strong W, Leystra-Lantz C, Shoesmith C. TDP43 is a human low molecular weight neurofilament (hNFL) mRNA-binding protein. Mol Cell Neurosci 2007; 35:320-7; PMID:17481916; http://dx.doi.org/10.1016/j.mcn.2007.03.007
32. Dani C, Blanchard JM, Piechaczyk M, El Sabouty S, Marty L, Jeanteur P. Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci U S A 1984; 81:7046-50; PMID:6594679; http://dx.doi.org/10.1073/pnas.81.22.7046
33. Ou SH, Wu F, Harrich D, Garcia-Martinez LF, Gaynor RB. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J Virol 1995; 69:3584-96; PMID:7745706
34. Buratti E, Dork T, Zuccato E, Pagani F, Romano M, Baralle FE. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 2001; 20:1774-84; PMID:11285240; http://dx.doi.org/10.1093/emboj/20.7.1774
35. Buratti E, De Conti L, Stuani C, Romano M, Baralle M, Baralle F. Nuclear factor TDP-43 can affect selected microRNA levels. FEBS J 2010; 277:2268-81; PMID:20423455; http://dx.doi.org/10.1111/j.1742-4658.2010.07643.x
36. Wang IF, Wu LS, Chang HY, Shen CK. TDP-43, the signature protein of FTLD-U, is a neuronal activityresponsive factor. J Neurochem 2008; 105:797-806; PMID:18088371; http://dx.doi.org/10.1111/j.1471-4159.2007.05190.x
37. Ayala YM, Pantano S, D'Ambrogio A, Buratti E, Brindisi A, Marchetti C, Romano M, Baralle FE. Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 2005; 348:575-88; PMID:15826655; http://dx.doi.org/10.1016/j.jmb.2005.02.038
38. Bhardwaj A, Myers MP, Buratti E, Baralle FE. Characterizing TDP-43 interaction with its RNA targets. Nucleic Acids Res 2013; 41:5062-74; PMID:23519609; http://dx.doi.org/10.1093/nar/gkt189
39. Freibaum BD, Chitta RK, High AA, Taylor JP. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. J Proteome Res 2010; 9:1104-20; PMID:20020773; http://dx.doi.org/10.1021/pr901076y
40. Volkening K, Leystra-Lantz C, Yang W, Jaffee H, Strong MJ. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS). Brain Res 2009; 1305:168-82; PMID:19815002; http://dx.doi.org/10.1016/j.brainres.2009.09.105
41. Morgan M, Iaconcig A, Muro AF. Identification of 3′gene ends using transcriptional and genomic conservation across vertebrates. BMC Genomics 2012; 13:708; PMID:23244605; http://dx.doi.org/10.1186/1471-2164-13-708
42. Ozsolak F, Kapranov P, Foissac S, Kim SW, Fishilevich E, Monaghan AP, John B, Milos PM. Comprehensive polyadenylation site maps in yeast and human reveal pervasive alternative polyadenylation. Cell 2010; 143:1018-29; PMID:21145465; http://dx.doi.org/10.1016/j.cell.2010.11.020
43. Ayala YM, Pagani F, Baralle FE. TDP43 depletion rescues aberrant CFTR exon 9 skipping. FEBS Lett 2006; 580:1339-44; PMID:16458894; http://dx.doi.org/10.1016/j.febslet.2006.01.052
44. Ayala YM, Zago P, D'Ambrogio A, Xu YF, Petrucelli L, Buratti E, Baralle FE. Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci 2008; 121:3778-85; PMID:18957508; http://dx.doi.org/10.1242/jcs.038950
45. Beilharz TH, Preiss T. Transcriptome-wide measurement of mRNA polyadenylation state. Methods 2009; 48:294-300; PMID:19233282; http://dx.doi.org/10.1016/j.ymeth.2009.02.003